Fulgent Genetics (FLGT) Gross Margin (2015 - 2026)
Fulgent Genetics (FLGT) posted Gross Margin of 30.07% for Q2 2026, little changed sequentially from 30.21% in Q1 2026, and down 1202.0% YoY from 2.73% in Q2 2025.
Fulgent Genetics (FLGT) Gross Margin (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported Gross Margin for 12 years, with the latest figure at 30.07% in Q2 2026.
- Quarterly Gross Margin fell 1202.0% year-over-year to 30.07% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 47.83% (up 779.0% YoY) and the FY2025 annual result came in at 40.56%, up 274.0% from the prior year.
- Gross Margin held at 30.07% in Q2 2026 per FLGT's latest filing, from 30.21% in the prior quarter.
- Over five years, Gross Margin peaked at 8145.5% in Q4 2025 and troughed at 15.53% in Q4 2022.
- A 5-year average of 489.33% and a median of 37.95% in 2024 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2025: Gross Margin slumped 5978 bps in 2022, then surged 810371 bps in 2025.
- Over 5 years, Gross Margin stood at 15.53% in 2022, then soared by 130 bps to 35.78% in 2023, then advanced by 17 bps to 41.79% in 2024, then surged by 19392 bps to 8145.5% in 2025, then tumbled by 100 bps to 30.07% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 30.07%, 30.21%, and 8145.5% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 57.64% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 64.58% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 32.85% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 64.04% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 63.29% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 29.80% |
| 10 | Fulgent Genetics | 557.44 Mn | 300.41 Mn | 25.68 Mn | 30.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.07% |
| Mar 31, 2026 | 30.21% |
| Dec 31, 2025 | 8,145.50% |
| Sep 30, 2025 | 42.24% |
| Jun 30, 2025 | 42.10% |
| Mar 31, 2025 | 38.59% |
| Dec 31, 2024 | 41.79% |
| Sep 30, 2024 | 37.32% |
| Jun 30, 2024 | 37.30% |
| Mar 31, 2024 | 34.28% |
| Dec 31, 2023 | 35.78% |
| Sep 30, 2023 | 47.05% |
| Jun 30, 2023 | 30.32% |
| Mar 31, 2023 | 28.43% |
| Dec 31, 2022 | 15.53% |
| Sep 30, 2022 | 43.63% |
| Jun 30, 2022 | 52.08% |
| Mar 31, 2022 | 75.73% |
| Dec 31, 2021 | 75.31% |
| Sep 30, 2021 | 80.92% |